Oxfendazole: a promising agent for the treatment and control of helminth infections in humans

References

• Geary TG, Woo K, McCarthy JS, et al. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol. 2010 Jan;40(1):1–13.
   PubMed Web of Science ®Google Scholar
• Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014;13:1202–1215.
   PubMed Web of Science ®Google Scholar
• 41-4-Oxfendazole. UN FAO web site 2003 [cited 2018 Jul 25]; Available from: https://web.archive.org/web/20170518153340/ftp.fao.org/ag/agn/jecfa/vetdrug/41-4-oxfendazole.pdf
   Google Scholar
• Codd EE, Ng HH, McFarlane C, et al. Preclinical studies on the pharmacokinetics, safety, and toxicology of oxfendazole: toward first in human studies. Int J Toxicol. 2015 Mar-Apr;34(2):129–137.
   PubMed Web of Science ®Google Scholar
• Villeneuve V, Beugnet F, Bourdoiseau G. Efficacy of oxfendazole for the treatment of giardiosis in dogs. Experiments in dog breeding kennels. Parasite. 2000;7(3):221–226.
   PubMed Web of Science ®Google Scholar
• Duncan JL, Reid JF. An evaluation of the efficacy of oxfendazole against the common nematode parasites of the horse. Vet Rec. 1978;103(15):332–334.
   PubMed Web of Science ®Google Scholar
• FDA. Animal & Veterinary NADA 140-854 Synanthic® - original approval- summary. 1990; Available from: https://web.archive.org/web/20171115071339/https://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/UCM478234.pdf
   Google Scholar
• Torres A, Plancarte A, Villalobos AN, et al. Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 3. Effect of 1-day treatment. Parasitol Res. 1992;78(2):161–164.
   PubMed Web of Science ®Google Scholar
• Gonzalez AE, Garcia HH, Gilman RH, et al. Treatment of porcine cysticercosis with albendazole. Am J Trop Med Hyg. 1995 Nov;53(5):571–574.
   PubMed Web of Science ®Google Scholar
• Gonzalez AE, Garcia HH, Gilman RH, et al. Effective, single-dose treatment or porcine cysticercosis with oxfendazole. Am J Trop Med Hyg. 1996 Apr;54(4):391–394.
   PubMed Web of Science ®Google Scholar
• Gonzalez AE, Falcon N, Gavidia C, et al. Treatment of porcine cysticercosis with oxfendazole: a dose-response trial. Vet Rec. 1997 Oct;141(16):420–422.
   PubMed Web of Science ®Google Scholar
• Mkupasi EM, Ngowi HA, Sikasunge CS, et al. Efficacy of ivermectin and oxfendazole against Taenia solium cysticercosis and other parasitoses in naturally infected pigs. Acta Trop. 2013 Oct;128(1):48–53.
   PubMed Web of Science ®Google Scholar
• Gonzalez AE, Falcon N, Gavidia C, et al. Time-response curve of oxfendazole in the treatment of swine cysticercosis. Am J Trop Med Hyg. 1998 Nov;59(5):832–836.
   PubMed Web of Science ®Google Scholar
• Gonzalez AE, Bustos JA, Jimenez JA, et al. Efficacy of diverse antiparasitic treatments for cysticercosis in the pig model. Am J Trop Med Hyg. 2012 Aug;87(2):292–296.
   PubMed Web of Science ®Google Scholar
• Gonzalez AE, Bustos JA, Garcia HH, et al. Successful antiparasitic treatment for cysticercosis is associated with a fast and marked reduction of circulating antigen levels in a naturally infected pig model. Am J Trop Med Hyg. 2015 Dec;93(6):1305–1310.
   PubMed Web of Science ®Google Scholar
• Vargas-Calla A, Gomez-Puerta LA, Calcina J, et al. Evaluation of activity of triclabendazole against Taenia solium metacestode in naturally infected pigs. Asian Pac J Trop Med. 2016 Jan;9(1):23–26.
   PubMed Web of Science ®Google Scholar
• Garcia HH, Gonzalez AE, Gilman RH, et al. Combined human and porcine mass chemotherapy for the control of T. solium. Am J Trop Med Hyg. 2006 May;74(5):850–855.
   PubMed Web of Science ®Google Scholar
• Gonzalez AE, Gavidia C, Falcon N, et al. Protection of pigs with cysticercosis from further infections after treatment with oxfendazole. Am J Trop Med Hyg. 2001 Jul;65(1):15–18.
   PubMed Web of Science ®Google Scholar
• Garcia HH, Gonzalez AE, Tsang VC, et al. Elimination of Taenia solium transmission in Northern Peru. N Engl J Med. 2016 Jun 16;374(24):2335–2344.
   PubMed Web of Science ®Google Scholar
• Chilundo AG, Johansen MV, Pondja A, et al. Piloting the effectiveness of pig health education in combination with oxfendazole treatment on prevention and/or control of porcine cysticercosis, gastrointestinal parasites, African swine fever and ectoparasites in Angónia District, Mozambique. Trop Anim Health Prod. 2018 Mar;50(3):589–601.
   PubMed Web of Science ®Google Scholar
• Okello AL, Thomas L, Inthavong P, et al. Assessing the impact of a joint human-porcine intervention package for Taenia solium control: results of a pilot study from northern Lao PDR. Acta Trop. 2016 Jul;159:185–191.
   PubMed Web of Science ®Google Scholar
• Pondja A, Neves L, Mlangwa J, et al. Use of oxfendazole to control porcine cysticercosis in a high-endemic area of Mozambique. PLoS Negl Trop Dis. 2012;6(5):e1651.
   PubMed Web of Science ®Google Scholar
• M.C.I.-Santé-Animale. Paranthic 10%-internal anthelminthic for cattle and swine, M.C.I. Mohammedia, MAROC: Santé Animale; 2015.
   Google Scholar
• WHO. (May 22, 2017) First ever licensed vaccine and anthelmintic against the major cause of epilepsy in the developing world. Neglected Tropical Diseases. Available from: http://www.who.int/neglected_diseases/news/First-licensed-vaccine-and-anthelmintic-against-epilepsy/en/
   Google Scholar
• Blanton RE, Wachira TM, Zeyhle EE, et al. Oxfendazole treatment for cystic hydatid disease in naturally infected animals. Antimicrob Agents Chemother. 1998 Mar;42(3):601–605.
   PubMed Web of Science ®Google Scholar
• Gavidia CM, Gonzalez AE, Lopera L, et al. Evaluation of nitazoxanide and oxfendazole efficacy against cystic echinococcosis in naturally infected sheep. Am J Trop Med Hyg. 2009 Mar;80(3):367–372.
   PubMed Web of Science ®Google Scholar
• Gavidia CM, Gonzalez AE, Barron EA, et al. Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep. PLoS Negl Trop Dis. 2010 Feb 23;4(2):e616.
   PubMed Web of Science ®Google Scholar
• Gomez-Puerta LA, Gavidia C, Lopez-Urbina MT, et al. Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheep. Am J Trop Med Hyg. 2012 Mar;86(3):486–488.
   PubMed Web of Science ®Google Scholar
• Gomez-Puerta LA, Gonzalez AE, Gavidia C, et al. Oxfendazole as successful treatment of Taenia hydatigena metacestodes in naturally infected pigs. Asian Pacific J Trop Biomed. 2015 Nov;5(11):971–973.
   Google Scholar
• Ngomuo A, Marriner S, Bogan J. The pharmacokinetics of fenbendazole and oxfendazole in cattle. Vet Res Communicat. 1984;8(1):187–193.
   PubMedGoogle Scholar
• Gokbulut C, Bilgili A, Hanedan B, et al. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs. Vet Parasitol. 2007;148:279–287.
   PubMed Web of Science ®Google Scholar
• Moreno L, Lopez-Urbina MT, Farias C, et al. A high oxfendazole dose to control porcine cysticercosis: pharmacokinetics and tissue residue profiles. Food Chem Toxicol. 2012;50(10):3819–3825.
   Web of Science ®Google Scholar
• Gow J Pharmacokinetics and bioavailability of oxfendazole in Sprague-Dawley rats. Menlo Park, CA: SRI International; 2010 November 3. (Report No. B381-10).
   Google Scholar
• Colella V, Maia C, Pereira A, et al. Evaluation of oxfendazole in the treatment of zoonotic Onchocerca lupi infection in dogs. PLoS Negl Trop Dis. 2018 Jan 29;12(1):e0006218.
   PubMed Web of Science ®Google Scholar
• Hubner MP, Martin C, Specht S, et al. Oxfendazole treatment has a macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca gutturosa adult worm motility in vitro. Abstract 2088, presented at the 67th Annual Meeting of the American Society of Tropical Medicne and Hygiene, November 1, 2018, New Orleans, USA.
   Google Scholar
• Mackenzie CD, Geary TG. Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs. Expert Rev Anti Infect Ther. 2011;9:497–501.
   PubMed Web of Science ®Google Scholar